Emerging Therapies in Prostate Cancer The radiopharmaceutical Alpharadin ® (Algeta, Oslo, Norway) has demonstrated the ability to improve survival along with palliative impact and is being ...

Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study ...

Bayer acquired the product for Algeta for 800 million in 2009, later paying out $2.9 billion for Algeta itself. Johnson & Johnson has reached a deal to acquire Shockwave Medical for around $13.1 ...

The firm has just sealed a deal to acquire Norwegian pharmaceutical firm Algeta for $2.62 billion. Bayer and Algeta have been collaborating since 2009 to develop and market Xofigo (radium-223 ...

Ms. Grønås has also held previous leadership and management roles at Algeta ASA, PhotoCure and Nycomed Imaging/Amersham Health (Now GE Healthcare). She holds a M. Pharm. degree from the ...

Abingworth began its VIPE foray in February 2009 when it joined a $35 million fundraising by Algeta, a Norwegian biotech company based in Oslo. Last October, it participated in a similar ...

Genzyme provides access to a novel tumor-targeting antibody, and Algeta will provide access to its Thorium platform to attach the alpha emitting payload thorium-227. The study, published in the ...